Tarsons Products Limited IPO (Tarsons Products IPO) Details,GMP, Subscription and Issue Price


Tarsons Products Limited IPO (Tarsons Products IPO) Detail

Details of the Tarsons Products Limited IPO - Tarsons IPO:

  1. Issue Amount: ₹1,024 Cr
  2. Face Value : ₹2 per share
  3. Price Band : ₹635 to ₹662
  4. Lot Size : 22 shares

Important dates for Tarsons Products Limited IPO - Tarsons IPO:

  1. IPO Open: Monday, November 15, 2021
  2. IPO Close: Wednesday, November 17, 2021
  3. Finalization of basis of allotment: 23rd November 2021
  4. Refunds/Unblocking ASBA fund: 24th November 2021
  5. Credit of equity shares to DP account: 25th November 2021
  6. Trading commences: 26th November 2021

Grey Market Premium of Tarsons Products Limited IPO:

In the following data we can see how the Grey Market Premium of Tarsons Products Limited varied in last few days
      • 16th Nov     -    Rs. 200 (30.2% to Issue Price of Rs. 662)
      • 16th Nov     -    Rs. 200 (30.2% to Issue Price of Rs. 662)
      • 15th Nov     -    Rs. 220 (33.2% to Issue Price of Rs. 662)
      • 13th Nov     -    Rs. 150
      • 12th Nov     -    Rs. 150
      • 11th Nov     -    Rs. 150
      • 10th Nov     -    Rs. 150

Tarsons Products Limited IPO Subscription on 17th November 2021:

Tarsons Products Limited IPO is subscribed 77.47 times on 17th November 2021 16:40 am
  • Qualified Institutional Buyers (QIB) - 115.77 times Subscribed
  • Retail Individual Investors (RII) - 10.52 times Subscribed
  • Non Institutional investors (NII) - 184.58 times Subscribed
  • Employees - 1.83 times Subscribed

Company background:

The company is an Indian labware company engaged in the designing, development, manufacturing and marketing of ‘consumables’, ‘reusables’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (“CROs”), Diagnostic companies and hospitals. The company manufactures a range of quality labware products which helps advance scientific discovery and improve healthcare (Source: Frost & Sullivan Report). As of June 30, 2021 it has a diversified product portfolio with over 1,700 SKUs across 300 products. The company caters to a diverse range of end customers across various sectors which include research organizations, academic institutions, pharmaceutical companies, CROs, diagnostic companies, and hospitals. Some of our end customers include customers such as Indian Institute of Chemical Technology, National Centre for Biological Sciences across academic institutes and research organizations; Dr Reddy's Laboratories, Enzene Biosciences across pharmaceutical sectors; Syngene International, Veeda Clinical Research across CROs; and Molbio Diagnostics, Agappe Diagnostic, Metropolis Healthcare, Dr. Lal Path Labs, Mylab Life Solutions across other sectors such as diagnostics. It distributes products to these end customers on a pan-India basis through its authorised distributors.
It is one of the leading Indian companies in terms of revenue in the plastic labware market in India which is estimated as ₹1,225 Cr as of 2020 in value terms and estimated to expand at a CAGR of 16.00% to reach approximately ₹2,575.5 Cr by year 2025. The company caters to the global plastic laboratory products market which was estimated to be USD 8.4 billion in 2020 and is expected to expand at a CAGR of approximately 10.50% to reach approximately USD 13.8 billion by year 2025 (Source: Frost & Sullivan Report). It supplies its products to over 40 countries across both developed and emerging markets through a blend of branded and ODMs.

Strengths Of the Tarsons Products Limited IPO:

Tarsons Products Limited IPO

Risks Associated with Tarsons Products Limited IPO:

Tarsons Products Limited IPO

Financial Details of Tarsons Products Limited IPO:

Tarsons Products Limited IPO

Purpose of Tarsons Products Limited IPO:

  • Repayment/prepayment of all or certain of the company’s borrowings 
  • Funding a part of the capital expenditure for the new manufacturing facility at Panchla, West Bengal (the “Proposed Expansion”) 
  • General corporate purposes
Disclaimer : This article is for educational purpose only and does not provide any buy or sell recommendation


Post a Comment

Popular posts from this blog

Post Office Investments for Small and Safe Investors In India

Wipro Share Returns In Last 40 years

Paras Defence And Space Technologies Limited IPO Details, GMP, Allotment Status and Issue Price

What is Investment ?

Which is better Investment plan PPF or VPF?

Best Ways To Save Money

Pradhan Mantri Vaya Vandana Yojana